新天地：与知和医药签署合作开发及许可协议
Henan Newland Pharmaceutical Henan Newland Pharmaceutical (SZ:301277) Zheng Quan Shi Bao Wang·2025-10-28 10:03

Core Viewpoint - The company has signed a cooperation and licensing agreement with Nanjing Zhihe Pharmaceutical Technology Co., Ltd. to develop GLP-1 class long-acting peptide innovative drugs [1] Group 1 - The collaboration will focus on the research, production, commercialization, and external transactions of target molecules and products in the GLP-1 long-acting peptide drug field [1] - The agreement includes clear stipulations regarding the rights and obligations of both parties involved in the cooperation [1]